Trinity Capital commits $35 million in gear financing to ApiJect (NASDAQ:TRIN)

Trinity Capital (NASDAQ:TRIN) Tuesday introduced the dedication of $35 million in gear financing to ApiJect Programs, a public-benefit medical know-how firm targeted on prefilled, single-dose injection units. Based mostly in Stamford, CT, ApiJect works with pharmaceutical corporations to design quickly scalable, cost-efficient drug supply programs, after which assists in manufacturing these units. The brand new facility from Trinity (TRIN) will permit ApiJect to maximise the worth of their exhausting belongings to proceed to scale operations and fund development initiatives. Supply: Press Launch